Yusuke Kimura, Yukinori Koyama, Kojiro Taura, Aoi Kudoh, Kanae Echizen, Daichi Nakamura, Xuefeng Li, Nguyen Hai Nam, Yusuke Uemoto, Takahiro Nishio, Gen Yamamoto, Satoru Seo, Keiko Iwaisako, Akira Watanabe, Etsuro Hatano – 22 May 2022
Tetsuya Tajima, Koichiro Hata, Jiro Kusakabe, Hidetaka Miyauchi, Kimiko Yurugi, Rie Hishida, Eri Ogawa, Tatsuya Okamoto, Mari Sonoda, Shoichi Kageyama, Xiangdong Zhao, Takashi Ito, Satoru Seo, Hideaki Okajima, Miki Nagao, Hironori Haga, Shinji Uemoto, Etsuro Hatano – 22 May 2022 – Donor–recipient human leukocyte antigen (HLA) compatibility has not been considered to significantly affect liver transplantation (LT) outcomes; however, its significance in living‐donor LT (LDLT), which is mostly performed between blood relatives, remains unclear.
Rachel Holmes, Anahli Patel, Archita P. Desai – 22 May 2022
Saad Saffo, Albert Do – 22 May 2022
Antonio D'Alessio, Claudia Angela Maria Fulgenzi, David J. Pinato – 22 May 2022
Thomas G. Cotter, Thomas Beresford – 22 May 2022
Amanda P. C. S. Boteon, Andrea Schlegel, Mauricio F. Carvalho, Yuri L. Boteon – 22 May 2022
Xuezhen Zeng, Guanrui Liao, Shumin Li, Haining Liu, Xiao Zhao, Shuang Li, Kai Lei, Shenghua Zhu, Zhihang Chen, Yi Zhao, Xuxin Ren, Tianhong Su, Alfred Sze‐Lok Cheng, Sui Peng, Shuibin Lin, Ji Wang, Shuling Chen, Ming Kuang – 21 May 2022
This special interest group aims to help patients with alcohol-associated liver disease through education and research that can drive advances in patient care and government and healthcare.
The mission of the Acute on Chronic Liver Failure SIG is to promote increased understanding of the changing landscape of research into patients with chronic liver disease and cirrhosis who develop acute deterioration of their condition. Through consortia and multi-center studies, the definition, prognostication and therapeutic strategies of acute-on-chronic liver failure are explored.
The overall goal is to generate interest and encourage continuing research into this fast-increasing condition.